Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine

BioMetals

Volumn 27, Issue 5, 2014, Pages 1017-1029

  Iigo, Masaaki ^a   Alexander, David B ^a   Xu, Jiegou ^a   Futakuchi, Mitsuru ^b   Suzui, Masumi ^b   Kozu, Takahiro ^c   Akasu, Takayuki ^c   Saito, Daizo ^c   Kakizoe, Tadao ^c   Yamauchi, Koji ^d   Abe, Fumiaki ^d   Takase, Mitsunori ^d   Sekine, Kazunori ^d   Tsuda, Hiroyuki ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Ancillary study of a human clinical trial; Human intestine; Immune function; Ingestion of bovine lactoferrin

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CEACAM8 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; KLRB1 PROTEIN, HUMAN; LACTOFERRIN; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ANIMAL; BLOOD; BOVINE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECTS; HUMAN; IMMUNOLOGY; INTESTINAL POLYPS; LARGE INTESTINE; METABOLISM; NATURAL KILLER CELL; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD; CALGRANULIN A; CALGRANULIN B; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; GPI-LINKED PROTEINS; HUMANS; INTESTINAL POLYPS; INTESTINE, LARGE; KILLER CELLS, NATURAL; LACTOFERRIN; NEUTROPHILS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B;

EID: 84920287470     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9747-2     Document Type: Article

References (36)

1. Alexander DB, Iigo M, Yamauchi K, Suzui M, Tsuda H (2012) Lactoferrin: an alternative view of its role in human biological fluids. Biochem Cell Biol 90(3):279-306. doi: 10.1139/o2012-013
2. Ambruso DR, Sasada M, Nishiyama H, Kubo A, Komiyama A, Allen RH (1984) Defective bactericidal activity and absence of specific granules in neutrophils from a patient with recurrent bacterial infections. J Clin Immunol 4(1):23-30
3. Anceriz N, Vandal K, Tessier PA (2007) S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. Biochem Biophys Res Commun 354(1):84-89. doi: 10.1016/j.bbrc.2006.12.203
4. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539-545. doi: 10.1016/S0140-6736(00)04046-0
5. Bhatnagar N, Hong HS, Krishnaswamy JK, Haghikia A, Behrens GM, Schmidt RE, Jacobs R (2010) Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood 116(8):1308-1316. doi: 10.1182/blood-2010-01-264903
6. Brown RD, Rickard KA, Kronenberg H (1983) Immunoradiometric assay of plasma lactoferrin. Pathology 15(1):27-31
7. Brown RD, Yuen E, Rickard KA, Vincent PC, Young G, Kronenberg H (1986) Plasma lactoferrin in patients with neutropenia. Blut 52(5):289-295
8. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL (2013) Functions of S100 proteins. Curr Mol Med 13(1):24-57
9. Freitas M, Porto G, Lima JL, Fernandes E (2008) Isolation and activation of human neutrophils in vitro. The importance of the anticoagulant used during blood collection. Clin Biochem 41(7-8):570-575. doi: 10.1016/j.clinbiochem.2007.12.021
10. Gebhardt C, Nemeth J, Angel P, Hess J (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72(11):1622-1631. doi: 10.1016/j.bcp.2006.05.017
11. Gessler P, Pretre R, Hohl V, Rousson V, Fischer J, Dahinden C (2004) CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 22(6):513-520
12. Goyette J, Geczy CL (2011) Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 41(4):821-842. doi: 10.1007/s00726-010-0528-0
13. Hsu K, Passey RJ, Endoh Y, Rahimi F, Youssef P, Yen T, Geczy CL (2005) Regulation of S100A8 by glucocorticoids. J Immunol 174(4):2318-2326
14. Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G (2011) S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 9(2):133-148. doi: 10.1158/1541-7786.MCR-10-0394
15. Kozu T, Iinuma G, Ohashi Y, Saito Y, Akasu T, Saito D, Alexander DB, Iigo M, Kakizoe T, Tsuda H (2009) Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila) 2(11):975-983. doi: 10.1158/1940-6207.CAPR-08-0208
16. Lande R, Giacomini E, Grassi T, Remoli ME, Iona E, Miettinen M, Julkunen I, Coccia EM (2003) IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 170(3):1174-1182
17. Lash JA, Coates TD, Lafuze J, Baehner RL, Boxer LA (1983) Plasma lactoferrin reflects granulocyte activation in vivo. Blood 61(5):885-888
18. Lim SY, Raftery M, Cai H, Hsu K, Yan WX, Hseih HL, Watts RN, Richardson D, Thomas S, Perry M, Geczy CL (2008) S-nitrosylated S100A8: novel anti-inflammatory properties. J Immunol 181(8):5627-5636
19. Lim SY, Raftery MJ, Goyette J, Hsu K, Geczy CL (2009) Oxidative modifications of S100 proteins: functional regulation by redox. J Leukoc Biol 86(3):577-587. doi: 10.1189/jlb.1008608
20. Megjugorac NJ, Young HA, Amrute SB, Olshalsky SL, Fitzgerald-Bocarsly P (2004) Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J Leukoc Biol 75(3):504-514. doi: 10.1189/jlb.0603291
21. Mozzanica N, Cattaneo A, Boneschi V, Brambilla L, Melotti E, Finzi AF (1990) Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon. Arch Dermatol Res 282(5):311-317
22. Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160(3):1427-1435
23. Queen MM, Ryan RE, Holzer RG, Keller-Peck CR, Jorcyk CL (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res 65(19):8896-8904. doi: 10.1158/0008-5472.CAN-05-1734
24. Roth J, Vogl T, Sunderkotter C, Sorg C (2003) Chemotactic activity of S100A8 and S100A9. J Immunol 171(11):5651
25. Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE, Tessier PA (2003) Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 48(8):2310-2320. doi: 10.1002/art.11079
26. Schnekenburger J, Schick V, Kruger B, Manitz MP, Sorg C, Nacken W, Kerkhoff C, Kahlert A, Mayerle J, Domschke W, Lerch MM (2008) The calcium binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cell-cell contacts. J Cell Physiol 216(2):558-567. doi: 10.1002/jcp.21433
27. Simard JC, Girard D, Tessier PA (2010) Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism. J Leukoc Biol 87(5):905-914. doi: 10.1189/jlb.1009676
28. Simard JC, Simon MM, Tessier PA, Girard D (2011) Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol 186(6):3622-3631. doi: 10.4049/jimmunol.1002956
29. Sroussi HY, Berline J, Dazin P, Green P, Palefsky JM (2006) S100A8 triggers oxidation-sensitive repulsion of neutrophils. J Dent Res 85(9):829-833
30. Tsuda H, Kozu T, Iinuma G, Ohashi Y, Saito Y, Saito D, Akasu T, Alexander DB, Futakuchi M, Fukamachi K, Xu J, Kakizoe T, Iigo M (2010) Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals 23:399-409. doi: 10.1007/s10534-010-9331-3
31. van den Tol MP, ten Raa S, van Grevenstein WM, van Rossen ME, Jeekel J, van Eijck CH (2007) The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils. Digit Surg 24(5):388-394. doi: 10.1159/000107781
32. van der Strate BW, Harmsen MC, The TH, Sprenger HG, de Vries H, Eikelboom MC, Kuipers ME, Meijer DK, Swart PJ (1999) Plasma lactoferrin levels are decreased in end-stage AIDS patients. Viral Immunol 12(3):197-203
33. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA (2003) Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171(5):2602-2609
34. Wada Y, Yoshida K, Tsutani Y, Shigematsu H, Oeda M, Sanada Y, Suzuki T, Mizuiri H, Hamai Y, Tanabe K, Ukon K, Hihara J (2007) Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines. Oncol Rep 17(1):161-167
35. Wislez M, Antoine M, Rabbe N, Gounant V, Poulot V, Lavole A, Fleury-Feith J, Cadranel J (2007) Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features. Clin Cancer Res 13(12):3518-3527. doi: 10.1158/1078-0432.CCR-06-2558
36. Zhao J, Endoh I, Hsu K, Tedla N, Endoh Y, Geczy CL (2011) S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma. Antioxid Redox Signal 14(9):1589-1600. doi: 10.1089/ars.2010.3583